Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
November 7, 2023
Nido Biosciences Presents Clinical Data Supporting the Continued Development of NIDO-361 in SBMA Patients at the 2023 International Kennedys Disease Patient Conference
November 7, 2023
Nouscoms Off-the-Shelf Cancer Vaccine, NOUS-209, Shows Potential to Intercept Cancer in Subjects with Lynch Syndrome
October 25, 2023
Skye Bioscience Announces Positive Phase 1 Trial Results for SBI-100 Ophthalmic Emulsion, Its First-in-Class CB1 Agonist Being Developed for the Treatment of Glaucoma
October 23, 2023
Precede Biosciences Unveils Groundbreaking Clinical Data for Its Pioneering Liquid Biopsy Platform at ESMO 2023 and Simultaneously Publishes in Nature Medicine
October 23, 2023
Potential of Arvinas’ PROTAC® AR Degraders Reinforced by 11.1 months rPFS with Bavdegalutamide and Updated Positive Interim Data from Second Generation ARV-766 in mCRPC
October 18, 2023
Precede Biosciences Announces First Scientific Data From Its Liquid Biopsy Platform to Be Presented as an Oral Presentation at ESMO 2023
October 17, 2023
Cidara Therapeutics and Mundipharma Receive Positive CHMP Opinion for Rezafungin for the Treatment of Invasive Candidiasis in Adults(1)
October 17, 2023
Radionetics Oncology Announces Initiation of Phase 1 Radiopharmaceutical Program Against Novel Target for Adrenocortical Carcinoma
October 17, 2023
Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262, a First-in-Class Oral MRGPRX2 Antagonist, in Chronic Spontaneous Urticaria
October 16, 2023
NodThera Announces First Patients Dosed in a Phase Ib/IIa Cardiovascular Risk Trial of NLRP3 Inflammasome Inhibitor NT-0796
« Previous Page
1
2
3
4
5
…
13
Next Page »